老年创伤患者的肋骨固定:对最脆弱患者的死亡率获益
该研究基于2016至2017年创伤质量改进项目(TQIP)数据库,纳入44,450例年龄>65岁、孤立性胸壁损伤伴多发肋骨骨折的患者,其中758例(1.7%)接受SSRF。经1:1倾向评分匹配后,SSRF组住院死亡率显著低于非手术组(4.2% vs 7.3%,p=0.01),但气管切开率(11.2% vs 4.6%)和呼吸机相关性肺炎(VAP)发生率(3.0% vs 1.6%)更高。对326对匹配患者进行的二次分析显示,早期(<72小时)SSRF与VAP减少(1.5% vs 4.6%)、机械通气天数减少(4天 vs 7天)、ICU住院时间缩短(6天 vs 9天)及总住院时间缩短(10天 vs 15天)相关。作者认为,早期SSRF可能与老年多发肋骨骨折患者预后改善相关。证据等级为治疗/护理管理,III级。
要点
- 在>65岁孤立性胸壁损伤伴多发肋骨骨折患者中,接受SSRF者住院死亡率显著低于非手术组(4.2% vs 7.3%,p=0.01)。
- SSRF组气管切开率(11.2% vs 4.6%,p<0.001)和VAP发生率(3.0% vs 1.6%,p=0.007)均高于非手术组。
- 早期(<72小时)SSRF与VAP减少(1.5% vs 4.6%,p=0.01)相关。
- 早期(<72小时)SSRF与机械通气天数减少(4天 vs 7天,p=0.003)、ICU住院时间缩短(6天 vs 9天,p=0.001)及总住院时间缩短(10天 vs 15天,p<0.001)相关。
- 作者认为,早期SSRF可能与老年多发肋骨骨折患者预后改善相关。
适用人群与场景
- 年龄>65岁、因孤立性胸壁损伤伴多发肋骨骨折入住创伤中心的患者(数据来自2016至2017年创伤质量改进项目数据库)。
研究设计与关键结果
- 研究类型:基于2016至2017年创伤质量改进项目数据库的分析;共纳入44,450例患者,其中758例(1.7%)接受SSRF。
- 接受SSRF的患者更年轻、连枷胸患病率更高、急诊室插管率更高、损伤严重度评分更高、ICU入住率更高。
- 经1:1倾向评分匹配后每组758例;SSRF组住院死亡率显著低于非手术组(4.2% vs 7.3%,p=0.01)。
- SSRF组气管切开率高于非手术组(11.2% vs 4.6%,p<0.001),VAP发生率亦高于非手术组(3.0% vs 1.6%,p=0.007)。
- 对326对匹配患者的二次分析显示,早期(<72小时)SSRF与VAP减少(1.5% vs 4.6%,p=0.01)相关。
- 早期(<72小时)SSRF与机械通气天数减少(4天 vs 7天,p=0.003)、ICU住院时间缩短(6天 vs 9天,p=0.001)及总住院时间缩短(10天 vs 15天,p<0.001)相关。
证据类型、等级与局限
- 证据类型:基于创伤质量改进项目数据库的治疗/护理管理研究,证据等级III级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该研究提示,在>65岁孤立性胸壁损伤伴多发肋骨骨折患者中,SSRF与住院死亡率降低相关,但气管切开率和VAP发生率更高。
- 作者认为,早期(<72小时)SSRF可能与VAP减少、ICU住院时间缩短及总住院时间缩短相关,可能改善老年多发肋骨骨折患者的预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Rib fractures in the geriatric trauma population are associated with significant morbidity and mortality. The outcomes of surgical stabilization of rib fractures (SSRF) have not been well defined in this population.
METHODS: Data from the 2016 to 2017 Trauma Quality Improvement Program database were analyzed. Patients older than 65 years admitted with isolated chest wall injury and multiple rib fractures were abstracted from the database. Multivariate propensity score matching was utilized to stratify patients that underwent rib fixation versus nonoperative management. In the matched cohort, we assessed outcomes including mortality, intensive care unit (ICU) and hospital lengths of stay (LOS), tracheostomy rates, and ventilator-associated pneumonia (VAP) rates. We performed a secondary analysis of patients receiving early (<72 hours) versus late SSRF.
RESULTS: Of the 44,450 patients included in the study analysis, 758 (1.7%) underwent SSRF. Patients undergoing SSRF were younger, had a higher prevalence of flail chest, higher rates of emergency room intubation, higher Injury Severity Score, and increased ICU admission rates. The 1:1 propensity score match resulted in 758 patients in each group. The in-hospital mortality rate was significantly lower in patients that underwent SSRF (4.2% vs. 7.3%, p = 0.01). However, the fixation group also had higher rates of tracheostomy during admission (11.2% vs. 4.6%, p < 0.001) and VAP (3.0% vs. 1.6%, p = 0.007). In a secondary matched analysis of 326 pairs of patients undergoing SSRF, we found that early fixation was associated with decreased rates of VAP (1.5% vs. 4.6%, p = 0.01), fewer ventilator days (4 days vs. 7 days, p = 0.003), shorter ICU LOS (6 days vs. 9 days, p = 0.001), and shorter hospital LOS (10 days vs. 15 days, p < 0.001).
CONCLUSION: This study demonstrates a mortality benefit in geriatric trauma patients undergoing SSRF. Early SSRF was observed to be associated with decreased rates of VAP, decreased ICU LOS, and decreased hospital LOS. Early SSRF may be associated with improved outcomes in the geriatric trauma population with multiple rib fractures.
LEVEL OF EVIDENCE: Therapeutic/Care management, level III.
参考来源
- Chen Zhu R, de Roulet A, Ogami T, et al. Rib fixation in geriatric trauma: Mortality benefits for the most vulnerable patients. J Trauma Acute Care Surg. 2020. PMID: 32176172. doi:10.1097/TA.0000000000002666
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。